Daniel J. Schneider

Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery

Larry Gold, Deborah Ayers, Jennifer Bertino et al. · PLoS ONE · 2010 · 1.7K citations · Full text

Life Sciences, Molecular Biology, Molecular Medicine +17

Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial

Kathy S. Albain, William E. Barlow, Peter M. Ravdin et al. · The Lancet · 2009 · 259 citations · Full text

Medicine, Gynecology, Oncology +17

Selection of DNA aptamers with two modified bases

Bharat Gawande, John C. Rohloff, Jeffrey D. Carter et al. · Proceedings of the National Academy of Sciences · 2017 · 195 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +15

High-affinity ssDNA inhibitors of the reverse transcriptase of type 1 human immunodeficiency virus

Daniel J. Schneider, Juli Feigon, Zdeněk Hostomský et al. · Biochemistry · 1995 · 165 citations

Pharmacy, Medicinal Chemistry, Molecular Biology +16

Chemically Modified DNA Aptamers Bind Interleukin-6 with High Affinity and Inhibit Signaling by Blocking Its Interaction with Interleukin-6 Receptor

Shashi Kumar Gupta, Masao Hirota, Sheela Waugh et al. · Journal of Biological Chemistry · 2014 · 150 citations · Full text

Life Sciences, Immunology, Molecular Biology +14